Clomicalm

by Novartis For Treatment Of Seperation Anxiety In Dogs

Clomicalm (clomipramine hydrochloride) Tablets work by making it easier for your dog to learn new, positive behaviors. The Clomicalm Plan is proven to be safe and effective in helping to relieve the suffering, and helping dogs with separation anxiety disorder return to a normal life.

More details

Novartis Clomicalm Tablets For Dogs At Discount Prices

Clomicalm Tablets For Dogs by Novartis

Clomipramine (Clomicalm) is a tricyclic antidepressant FDA approved for veterinary use in dogs for the treatment of separation anxiety. Clomipramine (Anafranil), FDA approved for human use, is sometimes used in veterinary medicine to treat aggression and obsessive-compulsive disorders such as tail chasing.

Prescription Required

Clomicalm For Dogs 20mg 30 Tablets Product Currently Unavailable
Clomicalm For Dogs 40mg 30 Tablets Product Currently Unavailable
Clomicalm For Dogs 80mg 30 Tablets Product Currently Unavailable

Clomicalm (clomipramine hydrochloride) Information

Generic Name: Clomipramine (klo-mip’-ra-meen)

Brand Name(s): Anafranil (Novartis), Clomicalm (Novartis)

Description:
CLOMICALM (clomipramine hydrochloride) Tablets belong to the dibenzazepine class of tricyclic antidepressants. Clomipramine hydrochloride is 3-chloro-5 [3-(dimethyl-amino)propyl]-10, 11-dihydro-5H-dibenz[b,f]azepine monohydrochloride. CLOMICALM Tablets are oblong, light brown in color and contain clomipramine hydrochloride formulated together with meat components. CLOMICALM Tablets are available in 20, 40 and 80 mg tablet strengths in color-coded packaging for oral administration to dogs.

Indications and Usage:
Clomicalm tablets are to be used as part of a comprehensive behavioral management program to treat separation anxiety in dogs greater than 6 months of age. Inappropriate barking or destructive behavior, as well as inappropriate elimination (urination or defecation) may be alleviated by the use of CLOMICALM Tablets in conjunction with behavior modification.

Separation anxiety is a complex behavior disorder displayed when the owner (or other attachment figure) leaves the dog. The signs of separation anxiety evaluated in controlled trials were vocalization, destructive behavior, excessive salivation and inappropriate elimination. In the absence of the owner or attachment figure, dogs with separation anxiety may exhibit one or more of these clinical signs. Although the owner (attachment figure) may inadvertently misinterpret this behavior, which only happens in their absence, as spiteful, it is thought to be the result of anxiety experienced by the dog. Punishment is not considered appropriate for a dog with separation anxiety.

Proper recognition of clinical signs, including a complete patient history and assessment of the patient's household environment, is essential to accurately diagnose and treat separation anxiety. The use of CLOMICALM Tablets should not replace appropriate behavioral and environmental management but should be used to facilitate a comprehensive behavioral management program.

.

Complete product information from Novartis